Streptokinase biosimilar (RAS Lifesciences)

链激酶生物类似药 (RAS Lifesciences)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameStreptokinase biosimilar (RAS Lifesciences)
Drug Alias Name链激酶生物仿制药 (RAS Lifesciences)
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionFibrinolysis stimulants
TargetsPlasminogen
Therapy Area/IndicationsThrombosis
Global Approved IndicationsThrombosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/10/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiomerieuxRas Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeB01AD01
Related LinksN/A